Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab

2 months ago
The Oncologist, Volume 25, Issue 6, Page e909-e919, June 2020.

Takahiro Kogawa,
Takeo Fujii,
Jimin Wu,
Kenichi Harano,
Tamer M. Fouad,
Diane D. Liu,
Yu Shen,
Hiroko Masuda,
Savitri Krishnamurthy,
Mariana Chavez‐MacGregor,
Bora Lim,
Rashmi K. Murthy,
Vicente Valero,
Debu Tripathy,
Naoto T. Ueno
Checked
16 minutes 12 seconds ago
Table of Contents for The Oncologist. List of articles from both the latest and EarlyView issues.
Subscribe to Early View from The Oncologist feed